Self-propagating abnormal proteins, prions, have been identified in yeast; asparagine/glutamine-rich 'prion domains' within these proteins can inactivate the linked functional domains; new prion domains and reporters have been used to make 'synthetic prions', leading to discoveries of new natural prions.
The term 'prion' means infectious protein, a concept originating in studies of the mammalian transmissible spongiform encephalopathies (TSEs), diseases believed to be caused by a self-propagating alteration of the PrP protein (reviewed in [1] [2] [3] ). In yeast, an infectious protein must, like a yeast virus, be a non-chromosomal genetic element that is transferred by cytoplasmic mixing [4] . To distinguish a prion from a virus or plasmid, three genetic criteria were proposed: first, if the prion can be 'cured', then it should arise again at some low frequency in the cured strain; second, overproduction of the protein should increase the frequency with which the prion arises de novo; and third, the gene encoding the protein should be necessary for propagation of the prion, and mutation of that gene should cause the same phenotype as the presence of the prion [4] .
Two non-chromosomal genetic elements in the budding yeast Saccharomyces cerevisiae, [URE3] and [PSI + ], satisfy these criteria for being prion forms of the proteins Ure2p and Sup35p, respectively [4] . In their normal states, Ure2p is a regulator of nitrogen catabolism [5] , while Sup35p is a subunit of the translation termination factor [6, 7] . Abundant supporting evidence confirms the assignment of [URE3] and [PSI + ] as prions. For example, Ure2p and Sup35p are protease-resistant in extracts of prion-containing cells [8, 9] , and aggregated in [URE3] and [PSI + ] cells [10, 11] . It is truly the protein whose overproduction induces the de novo appearance of the prions, and not the mRNAs or a high copy number of the genes [12, 13] . Another prion, [Het-s] of the filamentous fungus, Podospora anserina has also been found using the same genetic criteria [14] . The [Het-s] prion is of particular interest, as it is clearly necessary for a normal function of the fungal cells -heterokaryon incompatibility (reviewed in [15] ).
Ure2p and Sup35p can each be divided into an aminoterminal 'prion' domain and a carboxy-terminal functional domain [8, 16] . Overproduction of either prion domain can induce prion formation in trans; furthermore, each prion domain is necessary in cis for a protein to be functionally inactivated by a prion. In fact, the prion domains can propagate [URE3] [13] and [PSI + ] [16] without an attached functional domain (Figure 1 ). Both prion domains are very rich in asparagine and glutamine residues, and these residues are critical for the prion function [17, 18] . However, neither PrP, involved in the TSEs, nor the HET-s protein responsible for the [Het-s] prion, have asparagine/glutamine-rich regions. Remarkably, in both Ure2p and HET-s, it has been possible to identify two non-overlapping regions, either of which will induce the de novo appearance of the respective prion when overproduced [18, 19] . The amino-terminal prion domain of HET-s is only 25 residues in length. double-stranded RNA 'killer' viruses [21, 22] . Recently, two new approaches to finding prion domains have been developed. Both are based on the notion that prion domains and the functional domains they affect can be swapped. One method is to examine the amino termini of homologs of Sup35p to determine whether they have prion-promoting activity [23] [24] [25] . Sup35p homologs from the yeasts Pichia methanolica, Pichia pastoris, Candida albicans, Kluyveromyces lactis, Saccharomycodes ludwigii and Zygosaccharomyces rouxii all have carboxyl termini highly homologous to that of S. cerevisiae Sup35p. The amino termini are less homologous, but retain the high content of glutamine, asparagine and glycine and the imperfect oligopeptide repeats found in the S. cerevisiae protein [24, 26] .
The potential prion activities of these proteins were tested in S. cerevisiae, using fusions of the foreign aminoterminal domains to the functional carboxy-terminal part of the S. cerevisiae protein. The P. methanolica-S. cerevisiae hybrid protein could efficiently replace the essential Sup35 protein in its role in translation termination [23, 25] . Overexpression of this hybrid protein induced the appearance of clones in which translation termination was inefficient (observed as an increase in the suppression of nonsense mutations). The [PSI + ]-like trait of these strains was infectious via cytoplasmic transfer -like the known yeast viruses and prions -and could be cured by deletion of the heat-shock protein Hsp104 or growth in low concentrations of guanidine. This new non-chromosomal genetic element is denoted [PSI + PS ] to recall the hybrid character of its protein. The hybrid protein is aggregated in [PSI + PS ] strains, is partially protease-resistant in extracts, and can promote the co-aggregation of the normal form of the protein in vitro [25] . These observations make it clear that the hybrid protein can be a prion quite similar to [PSI + ]. Hybrid proteins with amino termini from C. albicans and K. lactis Sup35 proteins also showed properties expected of [PSI + ]-like prions [24] .
These hybrids have also been used to examine the 'species barrier' phenomenon in yeast (Figure 1) . Although many mammals spontaneously develop TSEs, transmission between species is delayed, or in many cases completely blocked because of differences between the sequences of the PrP proteins [27, 28] . The same phenomenon has been demonstrated using the hybrid Sup35 proteins in yeast [23] [24] [25] . The inactivation and aggregation of one hybrid was found to be independent of that of another, although one study detected low-level crossinduction of prion formation [23] . Santoso et al. [24] localized the specificity region of the prion domain to the amino-terminal 39 residues, the same region that this group showed was critical for prion propagation [17] .
What is the nature of the species barrier? Both Sup35p and Ure2p form amyloid in vitro, a reaction directed in each case by the prion domains of the proteins [29] [30] [31] . If we view the prions as amyloid -a kind of linear crystal [32] -then the species barrier is simply a reflection of the well-known interference with crystal formation of similar, but distinct molecules. Part of the the species barrier in mammalian TSEs involves the normal cellular form of the prion protein, PrP C , of one species interfering with infection by the scrapie form, PrP Sc , of another species [28] , an effect expected from the crystal model that has not yet been documented in yeast.
The second new approach to finding new prion domains exploits the fact that known yeast prion domains are asparagine-glutamine rich. Following this lead, the effects have been tested of fusing asparagine/glutamine-rich domains from other proteins to the known prion-sensitive functional domain of Sup35p [24, 33] . One such domain was from the protein encoded by the S. cerevisiae gene YPL226w, dubbed New1p [24] , while another was from the product of the gene YCL028w, named Rnq1p for rich in N (asparagine) and Q (glutamine) residues [33] . Each of these domains gave the Sup35p carboxy-terminal domain prion character. Rnq1p was shown to have alternative soluble and aggregated states in vivo, with the aggregated state the infectious form [33] .
Although the carboxy-terminal domains of Sup35p and Ure2p have virtues as tools to test potential prion domains, they are not necessarily ideal, and it is also of interest to know what proteins can be sensitive to prion inactivation. Li and Lindquist [34] have approached this aspect by making a fusion of the Sup35p prion domain to the glucocorticoid receptor, in cells whose synthesis of β-galactosidase is regulated by the glucocorticoid receptor. The Sup35p-glucocorticoid receptor hybrid behaved like a prion, with the glucocorticoid receptor activity nearly eliminated by the presence of [PSI + ]. In contrast, a fusion of the Ure2p prion domain to β-galactosidase did not lead to prion inactivation of the enzyme [8] . This suggests that proteins whose activity depends only on interaction with a small molecule may be unaffected by a prion, while those which must interact with another macromolecule or migrate to another compartment are better candidates as prion reporters.
These findings are an important step toward the goal of finding new prions. They show that the modular approach to isolation of prion domains is feasible. Are these already new prions? Some are, but others are not yet clear. A prion is infectious and infectivity for yeast prions and viruses means transfer to another cell by cytoplasmic mixing. Of course, aggregation is not necessarily a sign of a prion, nor need prions be aggregated. Not all fibrils are amyloid, and not all amyloidoses are infectious. The Ure2p [8] and Sup35p [35] prion domains are both dramatically stabilized by the normal carboxy-terminal domains of the respective proteins. Some regions capable of acting as prion domains in isolation from their normal protein environment may be incapable of doing so normally. This may be analogous to the finding that transcription activation domains are acidic regions and many acidic protein regions unrelated to transcription activators can still carry out this role [36] .
In the future, searches for new prion domains will not be limited to asparagine/glutamine-rich segments. It is expected that 'prion banks' could be screened to detect prion domains from any organism. The candidate domains will, however, have to be further examined in their natural protein environment to determine whether they are parts of true prions, or simply segments that, out of context, can aggregate.
